110 related articles for article (PubMed ID: 31322550)
1. MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma.
Huang D; Wang F; Wu W; Lian C; Liu E
Cancer Biomark; 2019; 26(1):63-68. PubMed ID: 31322550
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.
Su Z; Jiang G; Chen J; Liu X; Zhao H; Fang Z; He Y; Jiang X; Xu G
Mol Clin Oncol; 2020 Jan; 12(1):75-80. PubMed ID: 31814979
[TBL] [Abstract][Full Text] [Related]
3. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
4. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
6. The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.
Yoo JK; Jung HY; Lee JM; Yi H; Oh SH; Ko HY; Yoo H; Kim HR; Song H; Kim S; Kim JK
Cell Death Differ; 2014 Jul; 21(7):1150-9. PubMed ID: 24658401
[TBL] [Abstract][Full Text] [Related]
7. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
[TBL] [Abstract][Full Text] [Related]
8. microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway.
Cheng F; Yang Z; Huang F; Yin L; Yan G; Gong G
Microb Pathog; 2018 Aug; 121():110-114. PubMed ID: 29715534
[TBL] [Abstract][Full Text] [Related]
9. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.
Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818
[TBL] [Abstract][Full Text] [Related]
11. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
12. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Long J; Luo J; Yin X
Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
Zhang X; Wang S; Wang H; Cao J; Huang X; Chen Z; Xu P; Sun G; Xu J; Lv J; Xu Z
Mol Cancer; 2019 Feb; 18(1):20. PubMed ID: 30717751
[TBL] [Abstract][Full Text] [Related]
15. MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.
Li S; Ma Y; Hou X; Liu Y; Li K; Xu S; Wang J
Int J Clin Exp Pathol; 2015; 8(9):11854-62. PubMed ID: 26617940
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
17. miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.
Liu P; Hu Y; Ma L; Du M; Xia L; Hu Z
Biomed Pharmacother; 2015 Oct; 75():51-7. PubMed ID: 26463631
[TBL] [Abstract][Full Text] [Related]
18. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
19. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-204 inhibits the proliferation and metastasis of breast cancer cells by targeting PI3K/AKT pathway.
Fan X; Fang X; Liu G; Xiong Q; Li Z; Zhou W
J BUON; 2019; 24(3):1054-1059. PubMed ID: 31424660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]